Role of JAK/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial–mesenchymal transition

W Jin - Cells, 2020 - mdpi.com
The JAK/STAT3 signaling pathway plays an essential role in various types of cancers.
Activation of this pathway leads to increased tumorigenic and metastatic ability, the transition …

SOCS proteins in immunity, inflammatory diseases, and immune-related cancer

ML Sobah, C Liongue, AC Ward - Frontiers in medicine, 2021 - frontiersin.org
Cytokine signaling represents one of the cornerstones of the immune system, mediating the
complex responses required to facilitate appropriate immune cell development and function …

Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis

Z Guo, Y Zhang, W Xu, X Zhang, J Jiang - Journal of translational …, 2022 - Springer
Background Our previous study has identified a novel circRNA (circDIDO1) that is down-
regulated in gastric cancer (GC) and significantly inhibits GC progression. The purpose of …

Molecular mechanism involved in epithelial to mesenchymal transition

J Jayachandran, H Srinivasan, KP Mani - Archives of biochemistry and …, 2021 - Elsevier
Epithelial to mesenchymal transition (EMT) is a biological process that plays an important
role during embryonic development. During this process, the epithelial cells lose their …

m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation

J Xu, Q Chen, K Tian, R Liang, T Chen… - Oncology …, 2020 - spandidos-publications.com
Abstract N6‑methyladenosine (m6A) RNA modification maintained by N6‑
methyltransferases and demethylases is involved in multiple biological functions …

Accurate cancer cell identification and microRNA silencing induced therapy using tailored DNA tetrahedron nanostructures

J Su, F Wu, H Xia, Y Wu, S Liu - Chemical Science, 2020 - pubs.rsc.org
Accurate cancer cell identification and efficient therapy are extremely desirable and
challenging in clinics. Here, we reported the first example of DNA tetrahedron …

N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression

P Chen, S Li, K Zhang, R Zhao, J Cui, W Zhou, Y Liu… - Oncogene, 2021 - nature.com
Abstract N 6-Methyladenosine (m6A) is the most prevalent epigenetic RNA modification and
is vital in regulating malignancies. The roles of m6A modifiers on noncoding RNAs have not …

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives

F Seif, Z Torki, H Zalpoor, M Habibi… - Molecular Therapy …, 2023 - cell.com
The tumor microenvironment (TME) comprises a variety of immune cells, among which T
cells exert a prominent axial role in tumor development or anti-tumor responses in patients …

Urinary exosomal microRNAs as potential non-invasive biomarkers in breast cancer detection

M Hirschfeld, G Rücker, D Weiß, K Berner… - Molecular Diagnosis & …, 2020 - Springer
Introduction Breast cancer (BC) is the most frequent malignant disease in women worldwide
and is therefore challenging for the healthcare system. Early BC detection remains a leading …

The epigenetic and transcriptional landscape of neuroendocrine prostate cancer

A Davies, A Zoubeidi, LA Selth - Endocrine-related cancer, 2020 - erc.bioscientifica.com
Tumours adapt to increasingly potent targeted therapies by transitioning to alternative
lineage states. In prostate cancer, the widespread clinical application of androgen receptor …